TR200302008T4 - Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı. - Google Patents

Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.

Info

Publication number
TR200302008T4
TR200302008T4 TR2003/02008T TR200302008T TR200302008T4 TR 200302008 T4 TR200302008 T4 TR 200302008T4 TR 2003/02008 T TR2003/02008 T TR 2003/02008T TR 200302008 T TR200302008 T TR 200302008T TR 200302008 T4 TR200302008 T4 TR 200302008T4
Authority
TR
Turkey
Prior art keywords
medicament
beta
manufacture
treatment
adrenoceptor antagonists
Prior art date
Application number
TR2003/02008T
Other languages
English (en)
Inventor
J. ROBERT COLLIER Jr.
Michael Kapin A.
Louis Desantis Jr.
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of TR200302008T4 publication Critical patent/TR200302008T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu bulus, dis retina bozukluklarinin tedavisine yönelik bir ilaç üretiminde betaksolol gibi Beta-adrenoseptör antagonistlerinin kullanimi ile ilgilidir.
TR2003/02008T 1999-11-30 2000-11-29 Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı. TR200302008T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16799399P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
TR200302008T4 true TR200302008T4 (tr) 2004-01-21

Family

ID=22609644

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/02008T TR200302008T4 (tr) 1999-11-30 2000-11-29 Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.

Country Status (18)

Country Link
US (4) US7081482B2 (tr)
EP (1) EP1244438B1 (tr)
JP (2) JP4758581B2 (tr)
CN (1) CN1245966C (tr)
AT (1) ATE253905T1 (tr)
AU (1) AU782524B2 (tr)
BR (1) BR0015938A (tr)
CA (1) CA2388728C (tr)
DE (1) DE60006584T2 (tr)
DK (1) DK1244438T3 (tr)
ES (1) ES2210023T3 (tr)
HK (1) HK1047695B (tr)
MX (1) MXPA02005378A (tr)
PL (1) PL214875B1 (tr)
PT (1) PT1244438E (tr)
TR (1) TR200302008T4 (tr)
WO (1) WO2001043737A1 (tr)
ZA (1) ZA200203133B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1244438T3 (da) 1999-11-30 2004-02-23 Alcon Inc Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
CN100413503C (zh) * 2005-01-07 2008-08-27 冷文 一种复方眼药组合物
WO2008080110A1 (en) * 2006-12-21 2008-07-03 Alcon, Inc. Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor
KR20100133980A (ko) * 2008-03-07 2010-12-22 썬 파마 어드밴스트 리서치 컴패니 리미티드 안약 조성물
US10267796B2 (en) * 2010-10-25 2019-04-23 The Procter & Gamble Company Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis
MX2019012476A (es) * 2017-04-21 2020-02-12 Hoffman Steven Composiciones y metodos para tratar la retinopatia.
US11400070B2 (en) * 2018-05-03 2022-08-02 Alimera Sciences, Inc. Methods of treating retinal diseases
TWI776584B (zh) * 2020-07-10 2022-09-01 長庚醫療財團法人林口長庚紀念醫院 β-1腎上腺素受體拮抗劑用於製備減少表皮生長因子受體抑制劑誘導的上皮細胞損傷以及抑制癌細胞的組合物之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2330383A1 (fr) 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4443432A (en) 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
WO1998010758A1 (en) 1996-09-13 1998-03-19 The Regents Of The University Of California Methods for treatment of retinal diseases
BR9913955A (pt) * 1998-09-25 2001-06-12 Alcon Lab Inc Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular
DK1244438T3 (da) * 1999-11-30 2004-02-23 Alcon Inc Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde

Also Published As

Publication number Publication date
WO2001043737A1 (en) 2001-06-21
CN1245966C (zh) 2006-03-22
EP1244438A1 (en) 2002-10-02
JP2010215667A (ja) 2010-09-30
US7081482B2 (en) 2006-07-25
DE60006584D1 (de) 2003-12-18
US20020193373A1 (en) 2002-12-19
AU2052701A (en) 2001-06-25
PL214875B1 (pl) 2013-09-30
ES2210023T3 (es) 2004-07-01
DK1244438T3 (da) 2004-02-23
US20100249134A1 (en) 2010-09-30
PT1244438E (pt) 2004-02-27
US20080103211A1 (en) 2008-05-01
CA2388728C (en) 2009-05-19
HK1047695A1 (en) 2003-03-07
DE60006584T2 (de) 2004-09-30
US8710102B2 (en) 2014-04-29
AU782524B2 (en) 2005-08-04
JP2003516963A (ja) 2003-05-20
HK1047695B (zh) 2004-08-20
CA2388728A1 (en) 2001-06-21
ATE253905T1 (de) 2003-11-15
JP4758581B2 (ja) 2011-08-31
ZA200203133B (en) 2003-04-22
MXPA02005378A (es) 2005-02-25
CN1402634A (zh) 2003-03-12
PL356001A1 (en) 2004-05-31
BR0015938A (pt) 2002-08-27
US20060199868A1 (en) 2006-09-07
EP1244438B1 (en) 2003-11-12

Similar Documents

Publication Publication Date Title
IL225191A0 (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
WO2000038665A3 (en) Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
WO2000064441A3 (en) Compound for use as a medicament for treatment of disorders involving bronchocontraction
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
IL144643A0 (en) Jak-3 inhibitors for treating allergic disorders
TR200201322T2 (tr) H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı
IL163102A (en) Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
HK1074577A1 (en) The use of thymosin ß4 (Tß4), analogues, isoforms and other derivatives in the manufacture of a medicament for treating disorders of eye and the surrounding tissue
WO2003100574A3 (en) Dental appliances and systems and methods for distributing dental appliances
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
MXPA04004306A (es) Uso de antagonistas del receptor de endotelina para el tratamiento de enfermedades tumorales.
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
TR200302008T4 (tr) Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.
ZA200107143B (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
HK1016068A1 (en) Use of eliprodil for the manufacture of a medicament for the treatment of ischemic disorders of the retina of the optic nerve
WO2000061125A3 (fr) L'osanetant dans le traitement des troubles de l'humeur
WO2000076500A8 (en) Compound for use as a medicament for treatment of disorders involving bronchocontraction
MD1140C2 (ro) Remediu cu acţiune regenerativă şi citoprotectoare
MXPA05012696A (es) Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica.
WO2004012732A3 (en) Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions